Bone Marrow TransplantationBone MarrowTransplantation, AutologousCyclophosphamideBone Marrow CellsPeripheral Blood Stem Cell TransplantationTransplantation, HomologousHematopoietic Stem Cell TransplantationBone Marrow PurgingAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyGraft vs Host DiseaseWhole-Body IrradiationBone and BonesHematopoietic Stem CellsTransplantation ConditioningHematopoietic Stem Cell MobilizationLymphoma, Non-HodgkinBusulfanGranulocyte Colony-Stimulating FactorBone Marrow DiseasesMelphalanTreatment OutcomeLeukemiaCarmustineGraft SurvivalEtoposideHematopoiesisRemission InductionAnemia, AplasticRecurrenceAntigens, CD34Transplantation ChimeraLeukemia, Myeloid, AcuteColony-Forming Units AssayTime FactorsTissue DonorsHematologic NeoplasmsLeukapheresisBone Marrow ExaminationStem Cell TransplantationCytarabineHodgkin DiseaseSurvival AnalysisMultiple MyelomaThiotepaHistocompatibility TestingVincristineTransplantation, IsogeneicBone Marrow NeoplasmsHistocompatibilityStem CellsDisease-Free SurvivalPrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemia, MyeloidImmunosuppressive AgentsDoxorubicinSurvival RateAntineoplastic Agents, AlkylatingBone RemodelingLeukocyte CountMice, Inbred C57BLBlood Cell CountT-LymphocytesBlood Component RemovalFollow-Up StudiesLymphomaLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesLiver TransplantationSalvage TherapyAcute DiseaseFlow CytometryMyelodysplastic SyndromesBlood CellsCells, CulturedRetrospective StudiesImmunosuppressionRadiation ChimeraMethotrexateActuarial AnalysisPrognosisCell SeparationGranulocytesCell DifferentiationPlatelet CountAntibodies, MonoclonalAntineoplastic AgentsPrednisoneBone DensityLymphocyte DepletionImmunophenotypingHepatic Veno-Occlusive DiseaseDrug Administration SchedulePodophyllotoxinGranulocyte-Macrophage Colony-Stimulating FactorRecombinant ProteinsDrug EvaluationProspective StudiesCyclosporine